United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-804_3306a754-a59a-d003-e063-6294a90a65c9
- Product NDC
- 76420-804
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181221
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (76420-804-01) · 76420-804-01
- 500 CAPSULE in 1 BOTTLE (76420-804-05) · 76420-804-05
- 20 CAPSULE in 1 BOTTLE (76420-804-20) · 76420-804-20
- 30 CAPSULE in 1 BOTTLE (76420-804-30) · 76420-804-30
- 60 CAPSULE in 1 BOTTLE (76420-804-60) · 76420-804-60
- 90 CAPSULE in 1 BOTTLE (76420-804-90) · 76420-804-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →